Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 277

1.

Comparison of Two Questionnaires on Informed Consent in "Marginal" Donor Liver.

Bruzzone P, Balla A, Quaresima S, Seitaj A, Intini G, Giannarelli D, Paganini AM.

Transplant Proc. 2016 Mar;48(2):359-61. doi: 10.1016/j.transproceed.2015.12.053.

PMID:
27109955
2.

Molecular genetic alterations in egfr CA-SSR-1 microsatellite and egfr copy number changes are associated with aggressiveness in thymoma.

Conti S, Gallo E, Sioletic S, Facciolo F, Palmieri G, Lauriola L, Evoli A, Martucci R, Di Benedetto A, Novelli F, Giannarelli D, Deriu G, Granone P, Ottaviano M, Muti P, Pescarmona E, Marino M.

J Thorac Dis. 2016 Mar;8(3):386-95. doi: 10.21037/jtd.2016.02.40.

3.

Immunological markers and clinical outcome of advanced melanoma patients receiving ipilimumab plus fotemustine in the NIBIT-M1 study.

Maccalli C, Giannarelli D, Capocefalo F, Pilla L, Fonsatti E, Di Giacomo AM, Parmiani G, Maio M.

Oncoimmunology. 2015 Aug 12;5(2):e1071007. eCollection 2016 Feb.

PMID:
27057436
4.

Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice.

Metro G, Ricciuti B, Chiari R, Baretti M, Falcinelli L, Giannarelli D, Sidoni A, Mountzios G, Crinò L, Bellezza G, Rebonato A, Ferolla P, Toschi L.

Lung Cancer. 2016 May;95:82-7. doi: 10.1016/j.lungcan.2016.03.006. Epub 2016 Mar 15.

PMID:
27040856
5.

"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome.

Vici P, Pizzuti L, Sperduti I, Frassoldati A, Natoli C, Gamucci T, Tomao S, Michelotti A, Moscetti L, Gori S, Baldini E, Giotta F, Cassano A, Santini D, Giannarelli D, Di Lauro L, Corsi DC, Marchetti P, Sini V, Sergi D, Barba M, Maugeri-Saccà M, Russillo M, Mentuccia L, D'Onofrio L, Iezzi L, Scinto AF, Da Ros L, Bertolini I, Basile ML, Rossi V, De Maria R, Montemurro F.

Oncotarget. 2016 Feb 18. doi: 10.18632/oncotarget.7480. [Epub ahead of print]

6.

Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting.

Carbognin L, Pilotto S, Nortilli R, Brunelli M, Nottegar A, Sperduti I, Giannarelli D, Bria E, Tortora G.

Oncologist. 2016 Mar;21(3):283-91. doi: 10.1634/theoncologist.2015-0307. Epub 2016 Feb 10.

PMID:
26865589
7.

Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma.

Sabbatino F, Wang Y, Scognamiglio G, Favoino E, Feldman SA, Villani V, Flaherty KT, Nota S, Giannarelli D, Simeone E, Anniciello AM, Palmieri G, Pepe S, Botti G, Ascierto PA, Ferrone CR, Ferrone S.

J Natl Cancer Inst. 2016 Feb 5;108(7). pii: djv435. doi: 10.1093/jnci/djv435. Print 2016 Jul.

PMID:
26851802
8.

Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial.

Villani V, Zucchella C, Cristalli G, Galiè E, Bianco F, Giannarelli D, Carpano S, Spriano G, Pace A.

Head Neck. 2016 Apr;38 Suppl 1:E2118-21. doi: 10.1002/hed.24396. Epub 2016 Feb 5.

PMID:
26849799
9.

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.

Ferrucci PF, Ascierto PA, Pigozzo J, Del Vecchio M, Maio M, Antonini Cappellini GC, Guidoboni M, Queirolo P, Savoia P, Mandalà M, Simeone E, Valpione S, Altomonte M, Spagnolo F, Cocorocchio E, Gandini S, Giannarelli D, Martinoli C.

Ann Oncol. 2016 Apr;27(4):732-8. doi: 10.1093/annonc/mdw016. Epub 2016 Jan 22.

PMID:
26802161
10.

Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy.

Bottillo I, D'Angelantonio D, Caputo V, Paiardini A, Lipari M, De Bernardo C, Giannarelli D, Pizzuti A, Majore S, Castori M, Zachara E, Re F, Grammatico P.

Gene. 2016 Feb 15;577(2):227-35. doi: 10.1016/j.gene.2015.11.048. Epub 2015 Dec 2.

PMID:
26656175
11.

Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients.

Fabi A, Giannarelli D, Malaguti P, Ferretti G, Vari S, Papaldo P, Nisticò C, Caterino M, De Vita R, Mottolese M, Iacorossi L, Cognetti F.

Drug Des Devel Ther. 2015 Nov 20;9:6177-83. doi: 10.2147/DDDT.S89575. eCollection 2015.

12.

Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials.

Massari F, Modena A, Ciccarese C, Pilotto S, Maines F, Bracarda S, Sperduti I, Giannarelli D, Carlini P, Santini D, Tortora G, Porta C, Bria E.

Crit Rev Oncol Hematol. 2016 Feb;98:254-63. doi: 10.1016/j.critrevonc.2015.11.009. Epub 2015 Nov 17. Review.

PMID:
26638863
13.

Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method.

Di Filippo F, Giannarelli D, Bouteille C, Bernet L, Cano R, Cunnick G, Sapino A.

J Exp Clin Cancer Res. 2015 Nov 4;34:136. doi: 10.1186/s13046-015-0246-2.

14.

Cognitive rehabilitation training in patients with brain tumor-related epilepsy and cognitive deficits: a pilot study.

Maschio M, Dinapoli L, Fabi A, Giannarelli D, Cantelmi T.

J Neurooncol. 2015 Nov;125(2):419-26. doi: 10.1007/s11060-015-1933-8. Epub 2015 Sep 11.

PMID:
26362046
15.

Preperitoneal Continuous Infusion of Local Anesthetics: What Is the Impact on Surgical Wound Infections in Humans?

Claroni C, Marcelli ME, Sofra MC, Covotta M, Torregiani G, Giannarelli D, Forastiere E.

Pain Med. 2015 Aug 3. doi: 10.1111/pme.12872. [Epub ahead of print]

PMID:
26235038
16.

Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.

Koudriavtseva T, Plantone D, Renna R, Mandoj C, Giannarelli D, Mainero C.

Neurol Sci. 2015 Dec;36(12):2263-8. doi: 10.1007/s10072-015-2348-1. Epub 2015 Jul 26.

PMID:
26209931
17.

Improving cancer patients' knowledge about totally implantable access port: a randomized controlled trial.

Piredda M, Biagioli V, Giannarelli D, Incletoli D, Grieco F, Carassiti M, De Marinis MG.

Support Care Cancer. 2016 Feb;24(2):833-41. doi: 10.1007/s00520-015-2851-1. Epub 2015 Jul 24.

PMID:
26201750
18.

Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience.

Sciumè M, Vincenti D, Reda G, Orofino N, Cassin R, Giannarelli D, Gaidano G, Rossi D, Cortelezzi A.

Am J Hematol. 2015 Nov;90(11):970-4. doi: 10.1002/ajh.24127. Epub 2015 Aug 14.

PMID:
26201283
19.

Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy.

Mozzillo N, Simeone E, Benedetto L, Curvietto M, Giannarelli D, Gentilcore G, Camerlingo R, Capone M, Madonna G, Festino L, Caracò C, Di Monta G, Marone U, Di Marzo M, Grimaldi AM, Mori S, Ciliberto G, Ascierto PA.

Oncoimmunology. 2015 May 22;4(6):e1008842. eCollection 2015 Jun.

20.

Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by (90)Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma.

Pisani F, Sciuto R, Dessanti ML, Giannarelli D, Kayal R, Rea S, Marchesi F, Marino M.

Exp Hematol Oncol. 2015 Jun 24;4:17. doi: 10.1186/s40164-015-0012-3. eCollection 2015.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk